title: Hematologic complications of hepatitis A: another reason for implementation of anti-HAV vaccination.
authors.forename: Athanassios
authors.initials: A
authors.lastname: Chatzimichael
authors.forename: Maria
authors.initials: M
authors.lastname: Schoina
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Arvanitidou
authors.forename: Anna
authors.initials: A
authors.lastname: Ramatani
authors.forename: Elpis
authors.initials: E
authors.lastname: Mantadakis
mesh_terms: D000041:Absenteeism; D000328:Adult; D000367:Age Factors; D000741:Anemia, Aplastic / Q000453:epidemiology / Q000209:etiology*; D002648:Child; D006506:Hepatitis A / Q000150:complications* / Q000517:prevention & control; D022362:Hepatitis A Vaccines; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000209:etiology*; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D022362:Hepatitis A Vaccines